Exploring the genetic blueprint of cerebrospinal fluid proteins, this study uncovers new markers and therapeutic targets that may unlock advancements in Alzheimer’s diagnosis and care. Study: ...
Hosted on MSN
Protein ratio in cerebrospinal fluid outperforms traditional biomarkers in predicting Alzheimer's cognitive decline
A potential new biomarker for predicting future cognitive resilience versus decline among people with early Alzheimer's disease is described in Nature Medicine. This protein signature may improve the ...
Protein appears in nearly all body tissues, along with your enzymes, blood, and cerebrospinal fluid (CSF). Healthy CSF has a low amount of protein. If you show symptoms of an infection or nervous ...
Granulocyte-macrophage colony-stimulating factor (GM-CSF), also known as Colony Stimulating Factor 2 (granulocyte-macrophage), is a cytokine originally identified for its role in promoting the ...
Proteins floating in the cerebrospinal fluid might do more than diagnose Alzheimer’s disease—they may identify different subtypes, according to researchers led by Betty Tijms of the Amsterdam ...
A panel of 48 proteins in the cerebrospinal fluid (CSF 48 panel) complements existing CSF biomarkers for Alzheimer disease (AD), according to a study published in the Sept. 6 issue of Science ...
Research headed by teams at the University of Rochester Center for Translational Medicine and the University of Copenhagen describes for the first time how a spreading wave of disruption and the flow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results